zepbound glp-1 receptor agonist hydration effects 2025 Is a GLP-1? GLP-1 Agonists in Perimenopause: Unique

Data extraction and quality assessment The following data were extracted from the included RCTs by two authors independently: first authors name

Tirzepatide demonstrates superior fat-loss outcomes and greater improvements in glycemic control, likely due to its dual GLP-1 and GIP receptor action

By reducing this, GLP-1 drugs may protect organs and improve overall health

All other trials retrieved 139,140,141,142,143,144,146,147 investigated cardiometabolic parameters and were included in the meta-analyses above 134,137,138

Rohmann N, Schlicht K, Geisler C, Hollstein T, Knappe C, Krause L, et al

In trials, serious adverse events are uncommon and did not differ significantly from placebo (35)